Australia markets close in 5 hours 2 minutes

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.0300+0.0700 (+3.57%)
At close: 04:00PM EDT
1.9900 -0.04 (-1.97%)
After hours: 07:24PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.9600
Open1.9900
Bid1.7000 x 100
Ask2.3400 x 100
Day's range1.9900 - 2.0300
52-week range1.8400 - 4.7200
Volume7,063
Avg. volume23,475
Market cap23.411M
Beta (5Y monthly)1.04
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    TherapeuticsMD Announces Full Year 2023 Financial Results

    BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023.

  • Business Wire

    TherapeuticsMD Announces Third Quarter 2023 Financial Results

    BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2023.

  • Business Wire

    TherapeuticsMD Announces Second Quarter 2023 Financial Results

    BOCA RATON, Fla., August 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the second quarter ended June 30, 2023.